Search

everythinglearnresearchcommunity

for

Search:↓

Many patients with autoimmune blistering skin disorders change their diets, avoiding foods like alcohol, citrus, and spices, and some find vegetables and dairy helpful.

Most patients with autoimmune blistering diseases experienced some hair loss, which may be underreported and linked to disease severity.

Patients with autoimmune blistering diseases experience a reduced quality of life, with the need for better measurement tools, especially for those with mucous membrane pemphigoid.

New treatments and diagnostic methods for various animal skin conditions showed promising results.

The research found that certain characteristics like age, sex, race, marital status, and education level can influence whether alopecia patients stick to their hair loss treatment with topical minoxidil.

Dupilumab is effective and safe for treating moderate-to-severe atopic dermatitis in adolescents.

VB1953 gel significantly reduced acne and resistant bacteria in patients who didn't respond to clindamycin.

Rituximab treatment led to complete hair regrowth and improved skin in a woman with pemphigus foliaceus.

Sandalore®, a synthetic scent, improved hair loss and satisfaction in women with telogen effluvium.

Psoriasis is linked to other autoimmune diseases and involves a specific inflammatory process.

Laminin-511 may contribute to psoriasis by affecting skin cell growth and survival.

Patients using social media have mixed feelings about alopecia treatments, noting hair growth but also frustration with treatment recurrence.

The document is a detailed medical reference on skin and genetic disorders.

Small bowel lesions in Cronkhite-Canada syndrome persist despite steroid treatment.

Upadacitinib improved both Crohn's ileitis and alopecia universalis in a patient.

Arab APS1 patients have unique and recurrent AIRE gene mutations.

Baricitinib may effectively treat both alopecia areata and immune thrombocytopenia.

Abrocitinib, a JAK inhibitor, may help treat atopic dermatitis and alopecia universalis together.

Baricitinib helped improve hair, eyebrow, and eyelash growth in alopecia areata patients.

Baricitinib effectively improved both atopic dermatitis and alopecia areata symptoms in a patient.

Baricitinib treatment can help regrow scalp hair and eyebrows or eyelashes in people with severe alopecia areata.

Baricitinib is effective and safe for treating severe alopecia areata with ongoing use.

Baricitinib effectively promotes beard regrowth in most men with alopecia areata universalis.

Baricitinib helps regrow hair in adults with severe alopecia better than a placebo and is approved for treatment, but long-term effects are still unknown.

Baricitinib significantly regrows hair in teens with severe alopecia areata.

Two new IRAK4-inhibitors effectively reduced skin inflammation and immune response markers in healthy volunteers.

Baricitinib helps regrow scalp, eyebrow, and eyelash hair in teens with severe alopecia areata.

AIRE-deficient rats developed severe autoimmune disease similar to APECED, useful for testing treatments.